Helen Torley: CEO of Halozyme Therapeutics
Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.